MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,514,958 | -16.7% | 1,306,206 | +12.4% | 0.66% | -19.7% |
| Q2 2023 | $12,626,042 | +52.4% | 1,162,619 | -3.1% | 0.83% | +56.0% |
| Q1 2023 | $8,282,684 | +307.0% | 1,200,389 | +600.6% | 0.53% | +345.4% |
| Q4 2021 | $2,035,000 | +7.3% | 171,338 | +2.8% | 0.12% | +6.2% |
| Q3 2021 | $1,897,000 | -69.5% | 166,711 | -51.8% | 0.11% | -68.7% |
| Q2 2021 | $6,210,000 | +8.3% | 346,160 | -6.5% | 0.36% | +3.8% |
| Q1 2021 | $5,733,000 | +71.5% | 370,351 | +35.2% | 0.34% | +73.4% |
| Q4 2020 | $3,343,000 | – | 274,027 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $33,936,000 | 7.88% |
| VR Adviser, LLC | 3,156,803 | $29,516,000 | 4.78% |
| Bleichroeder LP | 1,322,463 | $12,365,000 | 2.19% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $13,380,000 | 1.30% |
| 683 Capital Management, LLC | 1,932,829 | $18,072,000 | 0.97% |
| Granite Point Capital Management, L.P. | 472,056 | $4,414,000 | 0.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,766,000 | $25,862,000 | 0.79% |
| Avoro Capital Advisors LLC | 3,150,000 | $29,453,000 | 0.54% |
| Artal Group S.A. | 1,000,000 | $9,350,000 | 0.39% |
| Stonepine Capital Management, LLC | 56,747 | $531,000 | 0.22% |